But because Wegovys indication aligns with weight management, it may fit your insurance criteria more cleanly
Everywhere you look it seems these medications, which mimic the hormone glucagon-like peptide-1, are being promoted
Potential contributors include rapid weight loss altering joint loading, inflammatory responses to medication initiation, dehydration, metabolic shifts affecting nutrient absorption, or direct GLP-1 receptor expression in muscle tissue
In that situation the responsible default is not assume it is fine unless proven harmful
One accidental intramuscular injection is unlikely to cause serious harm, but repeated muscle injections over weeks or months could lead to cumulative absorption problems and inconsistent treatment outcomes
Semaglutide bloating might be manageable for three months, then become unbearable